The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Rare Earths Stocks: 9 Biggest Companies in 2025

April 8, 2025

Crypto Market Recap: Bitcoin Price Hits New All-time...

May 22, 2025

Crypto Market Recap: Bitcoin sees Record Price Drop,...

March 12, 2025

Silver North Announces Closing of Second Tranche of...

June 30, 2024

Taroom Gas Infrastructure MOU Signed with AGIG

October 21, 2024

Opawica Explorations to Present at the Emerging Growth...

April 11, 2025

Cartier Resources Announces Subscription Agreement for Flow-Through Units...

April 2, 2025

Top 5 Canadian Mining Stocks This Week: Minsud...

February 22, 2025

Tariff Shock: Trillions Wiped Out as Trade War...

April 8, 2025

Silver Crown Royalties Announces Updates to Non-Brokered Private...

February 18, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,404)
    • Investing (3,391)
    • Politics (4,572)
    • World (4,505)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved